Amgen Balance Sheet | StatInvestor

Health Care & Life Sciences » Biotechnology | Amgen Inc.

Amgen Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.

2013

2014

2015

2016

2017

2018

Cash & Short Term Investments

19,401

27,026

31,382

38,085

41,678

29,304

Total Accounts Receivable

2,697

2,546

2,995

3,165

3,237

3,580

Inventories

3,019

2,647

2,435

2,745

2,834

2,940

Other Current Assets

2,250

2,494

1,703

2,015

1,727

1,794

Total Current Assets

27,367

34,713

38,515

46,010

49,476

37,618

Net Property, Plant & Equipment

5,349

5,223

4,907

4,961

4,989

4,958

Total Investments and Advances

3,807

544

579

655

719

683

Intangible Assets

28,230

27,481

26,428

25,030

23,370

22,142

Other Assets

1,372

1,048

1,020

970

1,400

1,015

Total Assets

66,125

69,009

71,449

77,626

79,954

66,416

ST Debt & Current Portion LT Debt

2,505

500

2,247

4,403

1,152

Accounts Payable

787

1,212

965

917

1,352

Other Current Liabilities

4,655

5,296

5,452

5,884

6,516

Total Current Liabilities

7,947

7,008

8,664

11,204

9,020

Long-Term Debt

29,623

30,215

29,182

30,193

34,190

Provision for Risks & Charges

1,973

2,419

9,099

Deferred Taxes

3,500

3,461

2,239

2,436

1,166

Other Liabilities

2,959

2,547

1,308

1,499

1,238

Total Liabilities

44,029

43,231

43,366

47,751

54,713

Common Equity (Total)

22,096

25,778

28,083

29,875

25,241

Total Shareholders' Equity

22,096

25,778

28,083

29,875

25,241

Total Equity

22,096

25,778

28,083

29,875

25,241

Liabilities & Shareholders' Equity

66,125

69,009

71,449

77,626

79,954

About Amgen

View Profile

Address	One Amgen Center Drive Thousand Oaks California 91320 United States
Employees	-
Website	http://www.amgen.com
Updated	07/08/2019
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K.